NRDY News & Events

The company states: "We are reaffirming our full year 2026 outlook of $180 to $190 million in revenue and approximately breakeven non-GAAP adjusted EBITDA, with year-end cash of $40 to $45 million inclusive of the $20 million currently drawn on our term loan. We are introducing second quarter guidance of $42 to $44 million in revenue and non-GAAP adjusted EBITDA of negative $2 million to breakeven. A note on Q2. Two mechanical dynamics shape that range. First, beginning in Q2 we lap the price increases enacted in February 2025, which moderates year-over-year ARPM growth in the Consumer business. Second, the lag between bookings and revenue recognition in our Institutional business means that Q1 institutional weakness flows through to Q2 revenue. Both were anticipated, and both are reflected in the full-year range we are reaffirming today."

Reports Q1 revenue $48.7M, consensus $47.3M. "In the first quarter, we exceeded the top end of our revenue guidance range and delivered positive non-GAAP adjusted EBITDA, both ahead of our guidance. Our non-GAAP adjusted EBITDA margin improved over 1,500 basis points year-over-year, reflecting the operating discipline and efficiency gains we've driven across every line of the P&L," said Chuck Cohn, Founder, Chairman and CEO of Nerdy. "We're building on this momentum in 2026 by improving our Learner and Expert experiences, growing our active member base, and delivering sustainable profitability."

Nerdy announced the appointment of Atul Bagga as Chief Financial Officer, effective April 6, 2026. In this role, Bagga will oversee Nerdy's global finance organization, including financial planning and analysis, accounting, tax, treasury, investor relations, and capital markets activities. Bagga joins Nerdy from JLL

Nerdy announced that it received a notice from the NYSE that it is not in compliance with the continued listing criteria under Section 802.01C of the NYSE Listed company manual because the average closing price of the company's Class A common stock was less than $1.00 over a consecutive 30 trading-day period. The company notified the NYSE on March 6 that it intends to cure the stock price deficiency and to return to compliance with the NYSE continued listing standard. The company can regain compliance at any time within the six-month period following receipt of the NYSE notice if on the last trading day of any calendar month during the cure period the company has a closing share price of at least $1.00 and an average closing share price of at least $1.00 over the 30 trading-day period ending on the last trading day of that month.